Trial Profile
The efficacy and safety of memantine in moderate to severe Alzheimer's disease
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 19 Jan 2010
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 11 Jul 2007 New trial record.